Medtronic (NYSE:MDT) has entered a definitive agreement to acquire Scientia Vascular, a maker of neurovascular access devices ...

Medtronic has announced its acquisition of Scientia Vascular for $550 million, aiming to enhance its neurovascular product ...

The Scientia deal follows Medtronic’s announcement in February that it’ll acquire CathWorks for up to $585 million.

The peripheral vascular device market will rise from $10.4B in 2025 to $14.8B by 2032, driven by drug‑coated balloons, ...

Peripheral artery disease (PAD) affects millions of Americans, yet access to timely, specialized care remains limited in many regions. The Rio Grande Valley, in particular, has historically faced a sc ...

Medtronic has bought a stroke-treating device firm for $550 million as the Fridley-operated medtech company executes its growth strategy of mergers and acquisitions. Scientia Vascular launched the ...

Verve Medical today announced the successful treatment of the first patient in a trial of its hypertension treatment.

Innovation, access, and compassion come together to preserve limbs and improve lives.Story by Matt McGarryAppeared in Cityview Magazine, Vol. 42, Issue 2 (March/April 2026)When APEX Vascular first ...

Brentwood, Tenn.-based Surgery Partners has acquired Preferred Vascular Group, an operator of ASCs focused on specialty dialysis access procedures. Preferred Vascular Group has eight ASCs in Georgia ...

Viper Partners, a healthcare-focused advisory firm, is pleased to announce that it served as the exclusive advisor to Vascular Specialists in its strategic partnership with CUC America, a leading ...

Medtronic said on Tuesday it has agreed ‌to buy U.S.-based Scientia Vascular ‌in a deal valued at $550 million, aiming to expand ​its line-up of products used in stroke care. Scientia, based in Salt ...

Medtronic announced today that it has entered into a definitive agreement to acquire Scientia Vascular for $550 million.